Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James E Hilbert

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Neurology|June 29, 2013
Diagnostic odyssey of patients with myotonic dystrophyJames E Hilbert, Tetsuo Ashizawa, John W Day, et al.
Contemporary Clinical Trials|December 14, 2011
If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD)James E Hilbert, John T Kissel, Elizabeth A Luebbe, et al.
The Journal of Molecular Diagnostics : JMD|May 18, 2013
Development of a genomic DNA reference material panel for myotonic dystrophy type 1 (DM1) genetic testingLisa Kalman, Jack Tarleton, Monica Hitch, et al.
Neurology|September 1, 2017
High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2James E Hilbert, Richard J Barohn, Paula R Clemens, et al.
Frontiers in Neurology|November 5, 2019
Reproductive Cancer Risk Factors in Women With Myotonic Dystrophy (DM): Survey Data From the US and UK DM RegistriesCecilia Higgs, James E Hilbert, Libby Wood, et al.
Muscle & Nerve|October 22, 2013
Myotonic Dystrophy Health Index: initial evaluation of a disease-specific outcome measureChad Heatwole, Rita Bode, Nicholas Johnson, et al.
Neurology|November 20, 2015
Patient-Reported Impact of Symptoms in Myotonic Dystrophy Type 2 (PRISM-2)Chad Heatwole, Nicholas Johnson, Rita Bode, et al.
JAMA|December 15, 2011
Cancer risk among patients with myotonic muscular dystrophyShahinaz M Gadalla, Marie Lund, Ruth M Pfeiffer, et al.
Archives of Neurology|September 15, 2010
Open-label trial of recombinant human insulin-like growth factor 1/recombinant human insulin-like growth factor binding protein 3 in myotonic dystrophy type 1Chad R Heatwole, Katy J Eichinger, Deborah I Friedman, et al.
Muscle & Nerve|June 6, 2015
Myotonic dystrophy health index: Correlations with clinical tests and patient functionChad Heatwole, Rita Bode, Nicholas E Johnson, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Neurology|June 29, 2013
Diagnostic odyssey of patients with myotonic dystrophyJames E Hilbert, Tetsuo Ashizawa, John W Day, et al.
Contemporary Clinical Trials|December 14, 2011
If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD)James E Hilbert, John T Kissel, Elizabeth A Luebbe, et al.
The Journal of Molecular Diagnostics : JMD|May 18, 2013
Development of a genomic DNA reference material panel for myotonic dystrophy type 1 (DM1) genetic testingLisa Kalman, Jack Tarleton, Monica Hitch, et al.
Neurology|September 1, 2017
High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2James E Hilbert, Richard J Barohn, Paula R Clemens, et al.
Frontiers in Neurology|November 5, 2019
Reproductive Cancer Risk Factors in Women With Myotonic Dystrophy (DM): Survey Data From the US and UK DM RegistriesCecilia Higgs, James E Hilbert, Libby Wood, et al.
Muscle & Nerve|October 22, 2013
Myotonic Dystrophy Health Index: initial evaluation of a disease-specific outcome measureChad Heatwole, Rita Bode, Nicholas Johnson, et al.
Neurology|November 20, 2015
Patient-Reported Impact of Symptoms in Myotonic Dystrophy Type 2 (PRISM-2)Chad Heatwole, Nicholas Johnson, Rita Bode, et al.
JAMA|December 15, 2011
Cancer risk among patients with myotonic muscular dystrophyShahinaz M Gadalla, Marie Lund, Ruth M Pfeiffer, et al.
Archives of Neurology|September 15, 2010
Open-label trial of recombinant human insulin-like growth factor 1/recombinant human insulin-like growth factor binding protein 3 in myotonic dystrophy type 1Chad R Heatwole, Katy J Eichinger, Deborah I Friedman, et al.
Muscle & Nerve|June 6, 2015
Myotonic dystrophy health index: Correlations with clinical tests and patient functionChad Heatwole, Rita Bode, Nicholas E Johnson, et al.
Pageof 3